Maciolek Natalie G. 4/A
4/A · MOLSON COORS BEVERAGE CO · Filed Mar 30, 2026
Research Summary
AI-generated summary of this filing
Molson Coors (TAP) CLO Natalie Maciolek Receives 40,614 Option Award
What Happened
- Natalie G. Maciolek, Chief Legal Officer of Molson Coors Beverage Co. (TAP), received a grant of 40,614 employee stock options (derivative "right to buy" shares) on March 4, 2026. The grant is reported with an acquisition price of $0.00 (no cash exchanged in the Form 4). This filing is an amendment correcting the originally reported number of options granted.
Key Details
- Transaction date: 2026-03-04 (grant); Form 4 originally filed 2026-03-06, amended 2026-03-30 to correct option count (Footnote F1).
- Type: Award/Grant of options (code A); recorded as a derivative (right to buy) — price listed $0.00.
- Vesting/Exercise: Options vest in full and become exercisable on 2029-03-04 (Footnote F2).
- Shares owned after transaction: Not specified in this filing.
- No exercise or sale reported: this is a compensation grant, not a purchase or sale of underlying shares.
Context
- These options give the holder the right to buy Molson Coors shares in the future (become exercisable on 3/4/2029). There was no immediate exercise or sale, so there is no immediate change in market ownership. Grants like this are typically part of executive compensation and should not be read as an immediate market-direction bet.
Insider Transaction Report
Form 4/AAmended
Maciolek Natalie G.
Chief Legal Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
[F1][F2]2026-03-04+40,614→ 40,614 totalExercise: $47.33Exp: 2036-03-04→ Class B Common Stock (40,614 underlying)
Footnotes (2)
- [F1]The original Form 4, filed on March 6, 2026, is being amended by this Form 4 to correct a calculation error that misreported the number of Employee Stock Options (Right to Buy) granted to the reporting person on March 4, 2026. This amendment correctly reports the number of Employee Stock Options (Right to Buy) granted to the reporting person on March 4, 2026.
- [F2]The stock options vest in full and become exercisable on March 4, 2029.
Signature
/s/ David P. Knaff, attorney-in-fact|2026-03-30